Cotinga Pharmaceuticals COTQF Stock
Cotinga Pharmaceuticals Price Chart
Cotinga Pharmaceuticals COTQF Financial and Trading Overview
| Cotinga Pharmaceuticals stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.0001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.0001 - 0.0001 USD |
| 52 Week Range | 1.0E-5 - 0.0001 USD |
| Volume | 6.5K USD |
| Avg. Volume | 0 USD |
| Market Cap | 2.2K USD |
| Beta (5Y Monthly) | 0.708032 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.86 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
COTQF Valuation Measures
| Enterprise Value | 425.77K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.199 |
Trading Information
Cotinga Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.708032 |
| 52-Week Change | 900.00% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-5 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 7.885E-5 USD |
COTQF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 21.99M |
| Float | 20.51M |
| Short Ratio | N/A |
| % Held by Insiders | 8.84% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | April 30, 2019 |
| Most Recent Quarter (mrq) | January 31, 2020 |
| Next Fiscal Year End | April 30, 2020 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -119.87% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -728244 USD |
| EBITDA | -2141954 USD |
| Net Income Avi to Common (ttm) | -2538439 USD |
| Diluted EPS (ttm) | -0.86 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 46.11K USD |
| Total Cash Per Share (mrq) | 0.002 USD |
| Total Debt (mrq) | 469.68K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.048 |
| Book Value Per Share (mrq) | -0.178 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -516139 USD |
| Levered Free Cash Flow (ttm) | 245.69K USD |
Profile of Cotinga Pharmaceuticals
| Country | United States |
| State | ON |
| City | Toronto |
| Address | The Canadian Venture Building |
| ZIP | M5C 1P1 |
| Phone | N/A |
| Website | https://www.cotingapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Q&A For Cotinga Pharmaceuticals Stock
What is a current COTQF stock price?
Cotinga Pharmaceuticals COTQF stock price today per share is 0.0001 USD.
How to purchase Cotinga Pharmaceuticals stock?
You can buy COTQF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cotinga Pharmaceuticals?
The stock symbol or ticker of Cotinga Pharmaceuticals is COTQF.
Which industry does the Cotinga Pharmaceuticals company belong to?
The Cotinga Pharmaceuticals industry is Biotechnology.
How many shares does Cotinga Pharmaceuticals have in circulation?
The max supply of Cotinga Pharmaceuticals shares is 21.98M.
What is Cotinga Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Cotinga Pharmaceuticals PE Ratio is now.
What was Cotinga Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Cotinga Pharmaceuticals EPS is -0.86 USD over the trailing 12 months.
Which sector does the Cotinga Pharmaceuticals company belong to?
The Cotinga Pharmaceuticals sector is Healthcare.